Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-JEV Envelope protein E Polyclonal Antibody

Catalog #:   PVV25701 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P32886
Overview

Catalog No.

PVV25701

Species reactivity

Japanese encephalitis virus (strain Jaoars982) (JEV)

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Japanese encephalitis virus (JEV) Envelope protein E (Phe295-Ala700).

Target

Genome polyprotein, Envelope protein E

Concentration

0.88 mg/ml

Purification

Antigen affinity purification.

Accession

P32886

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
References

Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide., PMID:40267616

Generation of soluble, immunoreactive recombinant JEV E protein through a simplified inclusion body extraction and refolding approach in vitro., PMID:39816339

A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses., PMID:39764453

An engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice., PMID:39588106

The Role of Complement Activation in IgM M-Protein-Associated Neuropathies., PMID:39571136

A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge., PMID:39085247

Japanese Encephalitis Virus Infection among Wild Caught Vectors Mosquitoes and Domestic Pigs in Northern West Bengal, India., PMID:38934834

Comparison of Five Serological Methods for the Detection of West Nile Virus Antibodies., PMID:38793670

[Preparation of monoclonal antibodies against the envelope protein extracellular domain of Zika virus in mice]., PMID:38790101

Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed., PMID:38659349

Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8+T cells., PMID:38643856

Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus., PMID:38618740

Molecular and serological evidence of chikungunya virus infection with high case fatality among pediatric population with acute encephalitis syndrome: first report from Eastern Uttar Pradesh, India., PMID:38557925

Epitope Mapping of Japanese Encephalitis Virus Neutralizing Antibodies by Native Mass Spectrometry and Hydrogen/Deuterium Exchange., PMID:38540792

Short Communication: Mosquito Histone 2A Protein Facilitate Japanese Encephalitis Virus Infection in the Mosquito., PMID:38441490

Low-temperature culture enhances production of flavivirus virus-like particles in mammalian cells., PMID:38416210

Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis., PMID:38189894

Shift in dominant genotypes of Japanese encephalitis virus and its impact on current vaccination strategies., PMID:38045034

CD4 is an important host factor for Japanese encephalitis virus entry and replication in PK-15 cells., PMID:38006719

N-linked glycosylation of flavivirus E protein contributes to viral particle formation., PMID:37819933

Mass-produced gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8+ T cells which enables an effective combination immunotherapy with anti-PD-1., PMID:37563797

Interaction between hTIM-1 and Envelope Protein Is Important for JEV Infection., PMID:37515282

Production of Plant-Derived Japanese Encephalitis Virus Multi-Epitope Peptide in Nicotiana benthamiana and Immunological Response in Mice., PMID:37511402

AB5-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus., PMID:37505694

Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement., PMID:37316861

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial., PMID:36758067

Virulence and Cross-Protection Conferred by an Attenuated Genotype I-Based Chimeric Japanese Encephalitis Virus Strain Harboring the E Protein of Genotype V in Mice., PMID:36301111

Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection., PMID:36146489

Prevalence and Genetic Characteristics of Japanese Encephalitis Virus among Mosquitoes and Pigs in Hunan Province, China from 2019 to 2021., PMID:36116917

Protective Immune Responses Induced by an mRNA-LNP Vaccine Encoding prM-E Proteins against Japanese Encephalitis Virus Infection., PMID:35746593

Japanese encephalitis genotype I virus-like particles stably expressed in BHK-21 cells serves as potential antigen in JE IgM ELISA., PMID:35175398

Evaluation of commercial serological assays in Malaysia for detection of anti-Zika virus antibodies., PMID:35001928

Electroactive reduced graphene oxide for highly sensitive detection of secretory non-structural 1 protein: A potential diagnostic biomarker for Japanese encephalitis virus., PMID:34864242

Immunogenicity and Protective Ability of Genotype I-Based Recombinant Japanese Encephalitis Virus (JEV) with Attenuation Mutations in E Protein against Genotype V JEV., PMID:34696184

Generation of soluble, disulfide-rich JEV NS1 protein recognizable by anti-NS1 antibodies through a simplified, in vitro refolding approach., PMID:34174313

Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit., PMID:33971403

Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles., PMID:33911132

Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells., PMID:33708358

FO-SPR biosensor calibrated with recombinant extracellular vesicles enables specific and sensitive detection directly in complex matrices., PMID:33664936

Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform., PMID:33643549

A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins., PMID:33022219

Actin reorganization at the centrosomal area and the immune synapse regulates polarized secretory traffic of multivesicular bodies in T lymphocytes., PMID:32939232

Serological and molecular epidemiology of Japanese Encephalitis in Zhejiang, China, 2015-2018., PMID:32853274

Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China., PMID:32831096

Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain., PMID:32619637

Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice., PMID:32584657

Peptide inhibitors of tembusu virus infection derived from the envelope protein., PMID:32456819

A novel protein chip for simultaneous detection of antibodies against four epidemic swine viruses in China., PMID:32456688

Membrane-binding peptides for extracellular vesicles on-chip analysis., PMID:32363015

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies., PMID:32265332

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-JEV Envelope protein E Polyclonal Antibody [PVV25701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only